肿瘤免疫

• Werewolf Therapeutics Completes $72 Million Series B Financing to Advance a Novel Class of Cancer Biotherapeutics to the Clinic 2021-01-07
• Ikena Oncology Closes $120 Million Series B Financing Led by Omega Funds 2021-01-05
• Gritstone Oncology Announces $110 Million Private Placement 2020-12-23
• Allterum Therapeutics completes Series Seed offering, builds team with addition of Philip Breitfeld as Chief Medical Officer 2020-12-17
• Scopus BioPharma Announces Pricing of Initial Public Offering 2020-12-16
• NANOBIOTIX Announces Closing of Global Offering and Full Exercise of Underwriters’ Option to Purchase Additional ADSs, Bringing Gross Proceeds of Global Offering to $113.3 Million 2020-12-16
• SELLAS Announces Pricing of $16.2 Million Registered Direct Offering 2020-12-14
• HOOKIPA Pharma Announces Closing of Public Offering of $80.9 Million of Common Stock and Preferred Stock, Including Full Exercise of Underwriters’ Option 2020-12-12
• ALX Oncology Announces Pricing of Upsized Public Offering of Common Stock 2020-12-10
• CG Oncology Closes $47 Million Series D Financing 2020-12-10

登录医药魔方官网 查看更多资讯